Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
0.1952
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 17th, 4:45 AM EDT
Detailed Quote
Previous Close
0.1952
Open
-
Bid
0.1757
Ask
0.1778
Day's Range
N/A - N/A
52 Week Range
0.0403 - 0.8960
Volume
292,747
Market Cap
299.76M
PE Ratio (TTM)
-1.775
EPS (TTM)
-0.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
164,144,962
Chart
About Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
Adaptimmune is a biotechnology company focused on developing T-cell therapy to treat cancer. The company specializes in harnessing the power of the immune system, particularly using engineered T-cell receptors (TCRs), to target and eliminate cancer cells more effectively. Adaptimmune’s innovative approach aims to improve patient outcomes in various cancers by personalizing therapies to the individual’s unique tumor characteristics. Through ongoing research and clinical trials, the company strives to bring transformative treatment options to patients suffering from life-threatening malignancies. Read More
Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
